Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026
Go back to Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 7.26 -0.24 (3.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.50 | 52 Week High | $44.38 | |||
| Open | $7.51 | 52 Week Low | $24.47 | |||
| Day High | $7.65 | P/E | 363.00 | |||
| Day Low | $7.24 | EPS | $0.02 | |||
| Volume | 554,005 | |||||
